Pharmaceuticals
Ranbaxy withdraws its antiretroviral''s from WHO list
By Ranbaxy decided on the w | 10 Nov 2004
Stronger performance from Shasun Chemicals and Drugs Limited
By Our Corporate Bureau | 18 Oct 2004
CII pharma summit for ''India pharma Inc''
By Our Corporate Bureau | 13 Oct 2004
Nicholas Piramal finalises product in-licensing agreement with Ethypharm, France
By Mumbai: | 18 Aug 2004
Fortis to invest over Rs1,100 crore in integrated healthcare delivery system
By Our Corporate Bureau | 17 Aug 2004
Nicholas Piramal in research collaboration with National Institute of Immunology
By Mumbai: | 12 Aug 2004
Dishman Pharma setting up new R&D facility
By The company''s R&D e | 11 Aug 2004
Nicholas Piramal seals an in-licensing agreement with Genzyme Corporation for the Indian market
By Mumbai: | 11 Aug 2004
Sun Pharmaceuticals proposes share swap with Phlox Pharma
By Our Corporate Bureau | 03 Aug 2004
Ranbaxy net down six per cent
By Total income during the | 02 Aug 2004
Charak Pharma in joint venture with IL&FS Investmart
By Nisha Das | 23 Jul 2004
India emerges as global hub for pharma outsourcing
By Pradeep Rane | 12 Jul 2004
Jagsonpal spreads its wings
By Our Corporate Bureau | 10 Jul 2004
Natco Pharma unveils new drug
By Our Corporate Bureau | 26 Jun 2004
Medicine Shoppe to double number of outlets this fiscal
By Sajeev Nair | 25 Jun 2004
Biological E to launch hepatitis-B vaccine `Bevac` in three months
By Our Corporate Bureau | 16 Jun 2004
Jagsonpal amongst India's top fifty pharma companies
By Our Corporate Bureau | 16 Jun 2004
Krebs to diversify
By Our Corporate Bureau | 31 May 2004
FIIs pull out of Dr Reddy''s Laboratories
By Nisha Das | 31 May 2004
Sun Pharma plants get US regulatory clearance
By Our Corporate Bureau | 28 May 2004
Two Sun Pharma units gets USFDA approval
By Our Corporate Bureau | 27 May 2004
Granules India gets USFDA nod
By Our Corporate Bureau | 24 May 2004
Orchid's US discovery JV successful
22 May 2004
Ipca launches India's first novel injectible antibiotic combination
By Our Corporate Bureau | 20 May 2004
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation